Vanda Pharmaceuticals to Announce Second Quarter 2025 Financial Results on July 31, 2025
Vanda Pharmaceuticals (Nasdaq: VNDA) has scheduled its second quarter 2025 financial results announcement for July 31, 2025, before market opening. The company will host a conference call at 8:00 AM ET on the same day to discuss the quarterly results and corporate activities.
Investors can participate by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) using passcode 9430387. The call will be simultaneously webcast on www.vandapharma.com. A replay will be available from 11:00 AM ET until August 7, 2025, at 11:59 PM ET.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 31 luglio 2025, prima dell'apertura del mercato. La societ脿 terr脿 una conference call alle 8:00 AM ET dello stesso giorno per discutere i risultati trimestrali e le attivit脿 aziendali.
Gli investitori potranno partecipare chiamando il numero 1-800-715-9871 (nazionale) o 1-646-307-1963 (internazionale) utilizzando il codice di accesso 9430387. La chiamata sar脿 trasmessa in diretta anche sul sito www.vandapharma.com. Una registrazione sar脿 disponibile in replica dalle 11:00 AM ET fino al 7 agosto 2025, alle 11:59 PM ET.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 31 de julio de 2025, antes de la apertura del mercado. La compa帽铆a realizar谩 una llamada conferencia a las 8:00 AM ET ese mismo d铆a para discutir los resultados trimestrales y las actividades corporativas.
Los inversores pueden participar llamando al 1-800-715-9871 (nacional) o al 1-646-307-1963 (internacional) usando el c贸digo de acceso 9430387. La llamada ser谩 transmitida simult谩neamente en www.vandapharma.com. Una repetici贸n estar谩 disponible desde las 11:00 AM ET hasta el 7 de agosto de 2025 a las 11:59 PM ET.
Vanda Pharmaceuticals (Nasdaq: VNDA)電� 2025雲� 2攵勱赴 鞛 瓴瓣臣 氚滍憸毳� 2025雲� 7鞗� 31鞚� 鞁滌灔 臧滌灔 鞝勳溂搿� 鞓堨爼頄堨姷雼堧嫟. 須岇偓電� 臧欖潃 雮� 鞓れ爠 8鞁� ET鞐� 攵勱赴 鞁れ爜瓿� 旮办梾 頇滊彊鞐� 雽�頃� 雲检潣頃橂姅 旎嵓霟办姢 旖滌潉 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愲摛鞚� 甑偞 鞝勴檾氩堩樃 1-800-715-9871 霕愲姅 甑牅 鞝勴檾氩堩樃 1-646-307-1963鞐� 鞝戩啀 旖旊摐 9430387毳� 靷毄頃� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 旖滌潃 www.vandapharma.com鞐愳劀 鞁れ嫓臧� 鞗轨簮鞀ろ姼搿滊弰 鞝滉车霅╇媹雼�. 雲轨潓鞚� 2025雲� 8鞗� 7鞚� 鞓ろ泟 11鞁� 59攵� ET旯岇 鞓れ爠 11鞁� ET攵�韯� 鞚挫毄 臧�電ロ暕雼堧嫟.
Vanda Pharmaceuticals (Nasdaq : VNDA) a programm茅 l'annonce de ses r茅sultats financiers du deuxi猫me trimestre 2025 pour le 31 juillet 2025, avant l'ouverture des march茅s. La soci茅t茅 organisera une conf茅rence t茅l茅phonique 脿 8h00 ET le m锚me jour pour discuter des r茅sultats trimestriels et des activit茅s de l'entreprise.
Les investisseurs peuvent participer en appelant le 1-800-715-9871 (num茅ro national) ou le 1-646-307-1963 (num茅ro international) avec le code d'acc猫s 9430387. La conf茅rence sera 茅galement diffus茅e en direct sur www.vandapharma.com. Un replay sera disponible de 11h00 ET jusqu'au 7 ao没t 2025 脿 23h59 ET.
Vanda Pharmaceuticals (Nasdaq: VNDA) hat die Bekanntgabe der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r den 31. Juli 2025, vor B枚rsen枚ffnung, geplant. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz abhalten, um die Quartalsergebnisse und Unternehmensaktivit盲ten zu besprechen.
Investoren k枚nnen teilnehmen, indem sie die Nummer 1-800-715-9871 (inl盲ndisch) oder 1-646-307-1963 (international) mit dem Zugangscode 9430387 w盲hlen. Der Anruf wird gleichzeitig auf www.vandapharma.com live 眉bertragen. Eine Aufzeichnung ist von 11:00 Uhr ET bis zum 7. August 2025, 23:59 Uhr ET, verf眉gbar.
- None.
- None.
Conference Call and Webcast to Follow
Vanda will host a conference call at 8:00 AM ET on Thursday, July 31, 2025, during which management will discuss the second quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 9430387.
The conference call will be broadcast simultaneously and archived on Vanda's website, . Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Thursday, July 31, 2025, beginning at 11:00 AM ET and will be accessible until Thursday, August 7, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 9430387.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit and follow us on X @vandapharma.
Corporate Contact:听
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer听
Vanda Pharmaceuticals Inc.
202-734-3400
[email protected]听
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
[email protected]听
View original content to download multimedia:
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When will Vanda Pharmaceuticals (VNDA) release Q2 2025 earnings?
How can investors join Vanda Pharmaceuticals' Q2 2025 earnings call?
What time is Vanda Pharmaceuticals' Q2 2025 earnings call?
How long will Vanda Pharmaceuticals' Q2 2025 earnings call replay be available?
